Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) Return on Assets (2021 - 2025)

Historic Return on Assets for Pharming (PHAR) over the last 5 years, with Q3 2025 value amounting to 0.05%.

  • Pharming's Return on Assets rose 1600.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.03% for FY2024, which is 200.0% down from last year.
  • According to the latest figures from Q3 2025, Pharming's Return on Assets is 0.05%, which was up 1600.0% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, Pharming's Return on Assets peaked at 0.14% during Q1 2022, and registered a low of 0.11% during Q2 2024.
  • In the last 5 years, Pharming's Return on Assets had a median value of 0.0% in 2021 and averaged 0.01%.
  • Per our database at Business Quant, Pharming's Return on Assets tumbled by -1700bps in 2024 and then skyrocketed by 1600bps in 2025.
  • Over the past 5 years, Pharming's Return on Assets (Quarter) stood at 0.11% in 2021, then crashed by -100bps to 0.0% in 2022, then crashed by -22888bps to 0.05% in 2023, then plummeted by -122bps to 0.1% in 2024, then skyrocketed by 152bps to 0.05% in 2025.
  • Its Return on Assets was 0.05% in Q3 2025, compared to 0.01% in Q2 2025 and 0.06% in Q1 2025.